Follow
Joan W. Miller
Joan W. Miller
Professor of Ophthalmology, Harvard Medical School
Verified email at meei.harvard.edu
Title
Cited by
Cited by
Year
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP ...
Arch ophthalmol 117, 1329-1345, 1999
19161999
Age-related macular degeneration
RD Jager, WF Mieler, JW Miller
New England Journal of Medicine 358 (24), 2606-2617, 2008
18002008
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
AP Adamis, JW Miller, MT Bernal, DJ D'Amico, J Folkman, TK Yeo, ...
American journal of ophthalmology 118 (4), 445-450, 1994
16231994
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult…
VIPTS Group1A
American journal of ophthalmology 131 (5), 541-560, 2001
983*2001
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
JW Miller, AP Adamis, DT Shima, PA D'Amore, RS Moulton, MS O'Reilly, ...
The American journal of pathology 145 (3), 574, 1994
9221994
Inhibition of vascular endothelial growth factor prevents retinal ischemia—associated iris neovascularization in a nonhuman primate
AP Adamis, DT Shima, MJ Tolentino, ES Gragoudas, N Ferrara, ...
Archives of ophthalmology 114 (1), 66-71, 1996
7981996
Prevention of experimental choroidal neovascularization with intravitreal anti–vascular endothelial growth factor antibody fragment
MG Krzystolik, MA Afshari, AP Adamis, J Gaudreault, ES Gragoudas, ...
Archives of ophthalmology 120 (3), 338-346, 2002
7622002
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
MJ Tolentino, JW Miller, ES Gragoudas, FA Jakobiec, E Flynn, ...
Ophthalmology 103 (11), 1820-1828, 1996
6701996
Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ...
Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010
5502010
VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization
S Ishida, T Usui, K Yamashiro, Y Kaji, S Amano, Y Ogura, T Hida, ...
The Journal of experimental medicine 198 (3), 483-489, 2003
5492003
Diffusion of high molecular weight compounds through sclera
J Ambati, CS Canakis, JW Miller, ES Gragoudas, A Edwards, ...
Investigative ophthalmology & visual science 41 (5), 1181-1185, 2000
4922000
Tumor necrosis factor- mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma
T Nakazawa, C Nakazawa, A Matsubara, K Noda, T Hisatomi, H She, ...
Journal of Neuroscience 26 (49), 12633-12641, 2006
4482006
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study
JW Miller, U Schmidt-Erfurth, M Sickenberg, CJ Pournaras, H Laqua, ...
Archives of ophthalmology 117 (9), 1161-1173, 1999
4431999
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate
MJ Tolentino, JW Miller, ES Gragoudas, K Chatzistefanou, N Ferrara, ...
Archives of Ophthalmology 114 (8), 964-970, 1996
4261996
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study
U Schmidt-Erfurth, JW Miller, M Sickenberg, H Laqua, I Barbazetto, ...
Archives of Ophthalmology 117 (9), 1177-1187, 1999
4051999
Vascular endothelial growth factor a in intraocular vascular disease
JW Miller, J Le Couter, EC Strauss, N Ferrara
Ophthalmology 120 (1), 106-114, 2013
3882013
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ...
Ophthalmology 110 (4), 667-673, 2003
3802003
Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy
JW Miller, AP Adamis, LP Aiello
Diabetes/metabolism reviews 13 (1), 37-50, 1997
3651997
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
CM Andreoli, JW Miller
Current opinion in ophthalmology 18 (6), 502-508, 2007
3582007
Interferon-associated retinopathy
DR Guyer, J Tiedeman, LA Yannuzzi, JS Slakter, D Parke, J Kelley, ...
Archives of Ophthalmology 111 (3), 350-356, 1993
3331993
The system can't perform the operation now. Try again later.
Articles 1–20